Robert Alexander Ingram, Director at OSI PHARMACEUTICALS INC (OSIP), sold 13,615 shares at $32.95 ($446K) on 2007-03-28, disclosed to the SEC on 2007-03-29.
Open-market sale of $446k OSIP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.69 | 100 | $3K | 0.7% |
| 2 | $32.70 | 100 | $3K | 0.7% |
| 3 | $32.72 | 100 | $3K | 0.7% |
| 4 | $32.57 | 200 | $7K | 1.5% |
| 5 | $32.58 | 400 | $13K | 2.9% |
| 6 | $32.59 | 300 |
| $10K |
| 2.2% |
| 7 | $32.63 | 387 | $13K | 2.8% |
| 8 | $32.64 | 413 | $13K | 3.0% |
| 9 | $32.65 | 600 | $20K | 4.4% |
| 10 | $32.67 | 600 | $20K | 4.4% |
| 11 | $32.68 | 300 | $10K | 2.2% |
| 12 | $32.69 | 500 | $16K | 3.7% |
| 13 | $32.70 | 1,000 | $33K | 7.3% |
| 14 | $32.72 | 400 | $13K | 2.9% |
| 15 | $32.76 | 900 | $29K | 6.6% |
| 16 | $32.78 | 300 | $10K | 2.2% |
| 17 | $32.80 | 200 | $7K | 1.5% |
| 18 | $32.81 | 300 | $10K | 2.2% |
| 19 | $32.82 | 600 | $20K | 4.4% |
| 20 | $32.83 | 700 | $23K | 5.2% |
| 21 | $32.84 | 1,227 | $40K | 9.0% |
| 22 | $32.85 | 700 | $23K | 5.2% |
| 23 | $32.86 | 300 | $10K | 2.2% |
| 24 | $32.87 | 473 | $16K | 3.5% |
| 25 | $32.88 | 500 | $16K | 3.7% |
| 26 | $32.89 | 600 | $20K | 4.4% |
| 27 | $32.90 | 300 | $10K | 2.2% |
| 28 | $32.91 | 800 | $26K | 5.9% |
| 29 | $32.94 | 115 | $4K | 0.8% |
| 30 | $32.95 | 200 | $7K | 1.5% |
| Total | $32.77 avg | 13,615 | $446K | 100% |
| Filing → |
| NOVN | BUY | 2019-05-23 | $111K | — | Filing → |
| NOVN | BUY | 2018-10-01 | $142K | — | Filing → |
| NOVN | BUY | 2017-08-29 | $55K | — | Filing → |